期刊文献+

国产麦迪霉素胃溶片的药代动力学和生物利用度研究

A PHARMACOKINETICS AND BIOAVAILABILITY STUDY OF MEDECAMYCIN IN HEALTHY VOLUNTEERS
下载PDF
导出
摘要 对国产和进口麦迪霉素的生物利用度进行了比较研究。10名健康志愿者交叉口服单剂量国产和进口麦迪霉素胃溶片600mg,应用HPLC法测定其血药浓度,并采用3P87程序处理实验数据。结果表明,麦迪霉素口服吸收表现为一室开放模型;口服国产与进口麦迪霉素胃溶片的Cmax分别为0.119和0.139mg/L,Tmax分别为0.50±0.45和0.45±0.34h,AUC分别为0.2015和0.2021mg/(h·L),经统计学处理,两者无显著差异(P>0.05),国产麦迪霉素胃溶片相对生物利用度为98.72%。 A single oral dose of 600mg Medecamycin controlled and domestics were given to 10 healthy male volunteers in a randomized cross over study.The Medecamycin concentrations in serum were determined by high performance liquid chromatography.The data obtained were treated with 3P87 practical pharmacokinetical program.The results showed that the serum concentration time curves of the two tablets were fitted to a one compartment model with first order absorption.Pharmacokinetics parameters of domestics and controlled Medecamycin:Cmax are 0.119 and 0.139g/L,Tmax are 0.5±0.45 and 0.45 ±0.34h,AUC are 0.2015 and 0.2021 mg/(L·h) respectively.The relative bioavailability of Medecamycin domestics to controlled was 98.72%.The results suggested that both tablets of Medecamycin have bioequivalance.
出处 《山东医科大学学报》 1998年第2期176-178,共3页 Acta Academiae Medicinae Shandong
关键词 麦迪霉素 药代动力学 生物利用度 胃溶片 HPLC Medecamycin HPLC pharmacokinetics Bioavailability
  • 相关文献

参考文献3

二级参考文献1

  • 1药物制剂人体生物利用度试验指导原则征求意见稿[J]中国临床药理学杂志,1992(03). 被引量:1

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部